Health Canada approves Pfizer and BioNTech’s Covid-19 vaccine for adolescents
With Health Canada authorisation, the Pfizer and BioNTech vaccine became the first-of-its-kind indicated for this age group to receive approval…
06 May 2021
Novo Nordisk reports increased Q1 2021 profit
The operating profit of Novo Nordisk decreased by 8% in local currency from kr16.3bn ($2.63bn) in last year's quarter to kr14.9bn ($2.4bn) this quarter but increased by 3% at constant…
06 May 2021
Novavax Covid-19 vaccine provides cross-protection against B.1.351 variant
The protein-based vaccine candidate NVX-CoV2373 is made from the genetic sequence of the first SARS-CoV-2 strain. It is adjuvanted with the company’s saponin-based Matrix-M to boost immune response and neutralising…
05 May 2021
Pfizer’s Covid-19 vaccine sales boost revenue in Q1 2021
Pfizer has increased 2021 financial guidance for its Covid-19 vaccine candidate BNT162b2 after the product generated $3.5bn in global revenues during the first quarter (Q1) of this year. The company’s…
05 May 2021
ViiV Healthcare starts rolling submission of cabotegravir for HIV prevention
ViiV Healthcare has begun a rolling submission of a new drug application (NDA) with the US Food and Drug Administration (FDA) for its long-acting cabotegravir to prevent human immunodeficiency virus…
05 May 2021
HDT Bio and Gennova dose healthy subjects in Covid-19 trial in India
HDT Bio and its development partner in India, Gennova Biopharmaceuticals, have started dosing healthy subjects with the Covid-19 vaccine in a Phase I/II trial in the country. Utilising a Lipid…
05 May 2021
eFFECTOR and QBI to study anti-viral agent for Covid-19 treatment
eFFECTOR Therapeutics and Quantitative Biosciences Institute (QBI) at the University of California, San Francisco (UCSF), have announced a $5m cooperative agreement for a planned Phase Ib study of zotatifin (eFT226),…
© Copyright Verdict Media Limited 2021
Powered by
